Duplication of the DR3 gene on human chromosome 1p36 and its deletion in human neuroblastoma

被引:27
作者
Grenet, J
Valentine, V
Kitson, J
Li, HM
Farrow, SN
Kidd, VJ
机构
[1] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38101 USA
[2] St Jude Childrens Res Hosp, Dept Expt Oncol, Memphis, TN 38101 USA
[3] Glaxo Wellcome Med Res Ctr, Cell Biol Unit, Stevenage SG1 2NY, Herts, England
关键词
D O I
10.1006/geno.1998.5300
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The human DR3 gene, whose product is also known as Wsl-1/APO-3/TRAMP/LARD, encodes a tumor necrosis factor-related receptor that is expressed primarily on the surface of thymocytes and lymphocytes. DR3 is capable of inducing both NF-kappa B activation and apoptosis when overexpressed in mammalian cells, although its ligand has not yet been identified. We report here that the DR3 gene locus is tandemly duplicated on human chromosome band 1p36.2-p36.3 and that these genes are hemizygously deleted and/or translocated to another chromosome in neuroblastoma (NB) cell lines with amplified MYCN. Duplication of at least a portion of the DR3 gene, including the extracellular and transmembrane regions but not the cytoplasmic domain, was demonstrated by both fluorescence in situ hybridization and genomic Southern blotting. In most NE cell lines, both the DR3 and the DR3L sequences are simultaneously deleted and/or translocated to another chromosome. Finally, DR3/Wsl-1 protein expression is quite variable among these NE cell lines, with very low or undetectable levels in 7 of 17 NE cell lines. (C) 1998 Academic Press.
引用
收藏
页码:385 / 393
页数:9
相关论文
共 37 条
  • [1] TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95)
    Bodmer, JL
    Burns, K
    Schneider, P
    Hofmann, K
    Steiner, V
    Thome, M
    Bornand, T
    Hahne, M
    Schroter, M
    Becker, K
    Wilson, A
    French, LE
    Browning, JL
    MacDonald, HR
    Tschopp, J
    [J]. IMMUNITY, 1997, 6 (01) : 79 - 88
  • [2] BRODEUR GM, 1994, SEMIN DIAGN PATHOL, V11, P118
  • [3] BRODEUR GM, 1992, CANCER-AM CANCER SOC, V70, P1685, DOI 10.1002/1097-0142(19920915)70:4+<1685::AID-CNCR2820701607>3.0.CO
  • [4] 2-H
  • [5] ALLELIC LOSS OF CHROMOSOME-1 AND ADDITIONAL CHROMOSOME-17 MATERIAL ARE BOTH UNFAVORABLE PROGNOSTIC MARKERS IN NEUROBLASTOMA
    CARON, H
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1995, 24 (04): : 215 - 221
  • [6] Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95
    Chinnaiyan, AM
    ORourke, K
    Yu, GL
    Lyons, RH
    Garg, M
    Duan, DR
    Xing, L
    Gentz, R
    Ni, J
    Dixit, VM
    [J]. SCIENCE, 1996, 274 (5289) : 990 - 992
  • [7] CONTENDERS IN FASL/TNF DEATH SIGNALING
    CLEVELAND, JL
    IHLE, JN
    [J]. CELL, 1995, 81 (04) : 479 - 482
  • [8] REPORT OF THE FIRST INTERNATIONAL WORKSHOP ON HUMAN-CHROMOSOME-1 MAPPING 1994 - HELD ON MARCH 25-27, 1994 AT BETHESDA, MD (USA)
    DRACOPOLI, NC
    BRUNS, GAP
    BRODEUR, GM
    LANDES, GM
    MATISE, TC
    SELDIN, MF
    VANCE, JM
    WEITH, A
    [J]. CYTOGENETICS AND CELL GENETICS, 1994, 67 (03): : 143 - 165
  • [9] INDUCTION OF APOPTOSIS IN FIBROBLASTS BY C-MYC PROTEIN
    EVAN, GI
    WYLLIE, AH
    GILBERT, CS
    LITTLEWOOD, TD
    LAND, H
    BROOKS, M
    WATERS, CM
    PENN, LZ
    HANCOCK, DC
    [J]. CELL, 1992, 69 (01) : 119 - 128
  • [10] A license to kill
    Fraser, A
    Evan, G
    [J]. CELL, 1996, 85 (06) : 781 - 784